SEC Form 4 · accession 0001114220-18-000082
KERYX BIOPHARMACEUTICALS INC · KERX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine A. Carberry
Officer — Chief Operating Officer
Period of report
Jul 18, 2018
Accepted (ET)
Jul 19, 2018 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001114220
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 18, 2018 | S | 2,021 | $4.49 | D | 113,155 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of a total of 2,021 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 7,084 shares of restricted stock on July 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- F2Includes 83,748 shares of restricted stock.